January 27, 2026 - 23:07

Major U.S. stock indices climbed higher on Tuesday, with the S&P 500 index approaching its all-time peak. The rally was largely fueled by significant gains in the technology sector, setting an optimistic tone on Wall Street ahead of a pivotal week for corporate results and central bank policy.
Investors displayed renewed confidence, focusing on upcoming earnings reports from several mega-cap tech giants. This anticipation helped overshadow lingering concerns about economic indicators and geopolitical tensions, driving buying activity in growth-oriented shares. The market's forward momentum suggests traders are betting on resilient corporate performance.
All eyes are now firmly fixed on the Federal Reserve's upcoming policy meeting conclusion. While the central bank is widely expected to hold interest rates steady, officials' commentary on the path of inflation and the future timing of potential rate cuts will be scrutinized for any shift in tone. The market's recent strength indicates hopes for a reaffirmation of a more accommodative policy stance later this year, but traders remain cautious of any hawkish surprises that could disrupt the current rally.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...